MoneyWorks4Me

Natco Pharma gets EIR from USFDA for API facility in Hyderabad

01 Oct 2019 Evaluate

Natco Pharma has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its Active Pharmaceutical Ingredient (API) facility in Mekaguda Village, Hyderabad which was conducted during the period August 5-9, 2019.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..